249 related articles for article (PubMed ID: 25863010)
41. Selective disruption of Tcf7l2 in the pancreatic β cell impairs secretory function and lowers β cell mass.
Mitchell RK; Mondragon A; Chen L; Mcginty JA; French PM; Ferrer J; Thorens B; Hodson DJ; Rutter GA; Da Silva Xavier G
Hum Mol Genet; 2015 Mar; 24(5):1390-9. PubMed ID: 25355422
[TBL] [Abstract][Full Text] [Related]
42. Associations between WNT signaling pathway-related gene polymorphisms and risks of osteoporosis development in Chinese postmenopausal women: a case-control study.
Yang Z; Liu J; Fu J; Li S; Chai Z; Sun Y
Climacteric; 2022 Jun; 25(3):257-263. PubMed ID: 34254535
[TBL] [Abstract][Full Text] [Related]
43. Diabetes-Associated Variation in TCF7L2 Is Not Associated With Hepatic or Extrahepatic Insulin Resistance.
Varghese RT; Viegas I; Barosa C; Marques C; Shah M; Rizza RA; Jones JG; Vella A
Diabetes; 2016 Apr; 65(4):887-92. PubMed ID: 26822092
[TBL] [Abstract][Full Text] [Related]
44. Loci of TCF7L2, HHEX and IDE on chromosome 10q and the susceptibility of their genetic polymorphisms to type 2 diabetes.
Nordman S; Ostenson CG; Efendic S; Gu HF
Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):186-90. PubMed ID: 19053027
[TBL] [Abstract][Full Text] [Related]
45. Transcription factor 7-like 2 (TCF7L2) gene polymorphisms are strong predictorsof type 2 diabetes among nonobese diabetics in the Turkish population.
Erkoç Kaya D; Arikoğlu H; Kayiş SA; Öztürk O; Gönen MS
Turk J Med Sci; 2017 Feb; 47(1):22-28. PubMed ID: 28263491
[TBL] [Abstract][Full Text] [Related]
46. Polymorphisms in lipid metabolism related miRNA binding sites and risk of metabolic syndrome.
Ye Q; Zhao X; Xu K; Li Q; Cheng J; Gao Y; Du J; Shi H; Zhou L
Gene; 2013 Oct; 528(2):132-8. PubMed ID: 23911300
[TBL] [Abstract][Full Text] [Related]
47. Type 2 diabetes mellitus susceptibility gene TCF7L2 is strongly associated with hyperglycemia in the Saudi Arabia Population of the eastern province of Saudi Arabia.
Acharya S; Al-Elq A; Al-Nafaie A; Muzaheed M; Al-Ali A
Eur Rev Med Pharmacol Sci; 2015 Aug; 19(16):3100-6. PubMed ID: 26367734
[TBL] [Abstract][Full Text] [Related]
48. Dietary saturated fat, gender and genetic variation at the TCF7L2 locus predict the development of metabolic syndrome.
Phillips CM; Goumidi L; Bertrais S; Field MR; McManus R; Hercberg S; Lairon D; Planells R; Roche HM
J Nutr Biochem; 2012 Mar; 23(3):239-44. PubMed ID: 21543200
[TBL] [Abstract][Full Text] [Related]
49. Single and multi-locus association study of TCF7L2 gene variants with susceptibility to type 2 diabetes mellitus in an Iranian population.
Kalantari S; Sharafshah A; Keshavarz P; Davoudi A; Habibipour R
Gene; 2019 May; 696():88-94. PubMed ID: 30776466
[TBL] [Abstract][Full Text] [Related]
50. Association between type 2 diabetes mellitus & TCF7L2 gene variants in the Emirati population: Genetics of diabetes in the United Arab Emirates.
Khan SM; El Karte N; El Hajj Chehadeh S; Hassoun A; Afandi B; Tay GK; Alsafar H
Am J Hum Biol; 2021 Jan; 33(1):e23434. PubMed ID: 32445548
[TBL] [Abstract][Full Text] [Related]
51. Association of the rs11196218 polymorphism in TCF7L2 with type 2 diabetes mellitus in Asian population.
Zhai Y; Zhao J; You H; Pang C; Yin L; Guo T; Feng T; Wang C; Gao K; Luo X; Zhang M; Wang J; Li L; Wang B; Ren Y; Shen Y; Zhu T; Hu D
Meta Gene; 2014 Dec; 2():332-41. PubMed ID: 25606417
[TBL] [Abstract][Full Text] [Related]
52. The type 2 diabetes susceptibility TCF7L2 gene variants affect postprandial glucose and fat utilization in non-diabetic subjects.
Adamska E; Kretowski A; Goscik J; Citko A; Bauer W; Waszczeniuk M; Maliszewska K; Paczkowska-Abdulsalam M; Niemira M; Szczerbinski L; Ciborowski M; Gorska M
Diabetes Metab; 2018 Sep; 44(4):379-382. PubMed ID: 28579156
[No Abstract] [Full Text] [Related]
53. Pleiotropic effects of TCF7L2 gene variants and its modulation in the metabolic syndrome: from the LIPGENE study.
Delgado-Lista J; Perez-Martinez P; García-Rios A; Phillips CM; Williams CM; Gulseth HL; Helal O; Blaak EE; Kiec-Wilk B; Basu S; Drevon CA; Defoort C; Saris WH; Wybranska I; Riserus U; Lovegrove JA; Roche HM; Lopez-Miranda J
Atherosclerosis; 2011 Jan; 214(1):110-6. PubMed ID: 21115178
[TBL] [Abstract][Full Text] [Related]
54. Impact of TCF7L2 single nucleotide polymorphisms on hydrochlorothiazide-induced diabetes.
Karnes JH; Gong Y; Pacanowski MA; McDonough CW; Arwood MJ; Langaee TY; Pepine CJ; Johnson JA; Cooper-Dehoff RM
Pharmacogenet Genomics; 2013 Dec; 23(12):697-705. PubMed ID: 24128935
[TBL] [Abstract][Full Text] [Related]
55. Association of genetic variations in TCF7L2, SLC30A8, HHEX, LOC387761, and EXT2 with Type 2 diabetes mellitus in Tunisia.
Kifagi C; Makni K; Boudawara M; Mnif F; Hamza N; Abid M; Granier C; Ayadi H
Genet Test Mol Biomarkers; 2011 Jun; 15(6):399-405. PubMed ID: 21510814
[TBL] [Abstract][Full Text] [Related]
56. The Role of
Del Bosque-Plata L; Martínez-Martínez E; Espinoza-Camacho MÁ; Gragnoli C
Diabetes; 2021 Jun; 70(6):1220-1228. PubMed ID: 34016596
[No Abstract] [Full Text] [Related]
57. Polymorphisms of the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with obesity phenotypes in a large family-based association study.
Guo YF; Xiong DH; Shen H; Zhao LJ; Xiao P; Guo Y; Wang W; Yang TL; Recker RR; Deng HW
J Med Genet; 2006 Oct; 43(10):798-803. PubMed ID: 16723389
[TBL] [Abstract][Full Text] [Related]
58. What Can Diabetes-Associated Genetic Variation in TCF7L2 Teach Us About the Pathogenesis of Type 2 Diabetes?
Adams JD; Vella A
Metab Syndr Relat Disord; 2018 Oct; 16(8):383-389. PubMed ID: 29993315
[TBL] [Abstract][Full Text] [Related]
59. Association of TCF7L2 SNPs with age at onset of type 2 diabetes and proinsulin/insulin ratio but not with glucagon-like peptide 1.
Silbernagel G; Renner W; Grammer TB; Hügl SR; Bertram J; Kleber ME; Hoffmann MM; Winkelmann BR; März W; Boehm BO
Diabetes Metab Res Rev; 2011 Jul; 27(5):499-505. PubMed ID: 21384500
[TBL] [Abstract][Full Text] [Related]
60. Lack of association between TCF7L2 gene variants and type 2 diabetes mellitus in a Brazilian sample of patients with the risk for cardiovascular disease.
Wunsch C; Dornelles TF; Girardi P; Arndt ME; Genro JP; Contini V
Endocr Regul; 2019 Jan; 53(1):1-7. PubMed ID: 31517619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
